These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 19764381)

  • 21. [No documentation for overtreatment with statins].
    Jensen GB
    Ugeskr Laeger; 2011 Sep; 173(38):2363; author reply 2363. PubMed ID: 22034664
    [No Abstract]   [Full Text] [Related]  

  • 22. Lowering copayments: impact of simvastatin patent expiration on patient adherence.
    Sedjo RL; Cox ER
    Am J Manag Care; 2008 Dec; 14(12):813-8. PubMed ID: 19067498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.
    Mihaylova B; Briggs A; Armitage J; Parish S; Gray A; Collins R;
    Lancet; 2005 May 21-27; 365(9473):1779-85. PubMed ID: 15910950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Which statin is more efficient? Concepts and applications in economic evaluation].
    García-Altés A; Jovell AJ
    Aten Primaria; 2000 Sep; 26(5):333-8. PubMed ID: 11100606
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical inquiries. What are effective medication combinations for dyslipidemia?
    Saseen J; Tweed E; Crawford P
    J Fam Pract; 2006 Jan; 55(1):70-2. PubMed ID: 16388773
    [No Abstract]   [Full Text] [Related]  

  • 26. [By JUPITER! Disease mongering!].
    Welin L; Peterson M
    Lakartidningen; 2008 Dec; 105(51-52):3756; discussion 3756-7. PubMed ID: 19278103
    [No Abstract]   [Full Text] [Related]  

  • 27. Statins: putting the benefit/risk into perspective.
    Shepherd J
    Int J Clin Pract Suppl; 2003 Oct; (137):27-33. PubMed ID: 14649699
    [No Abstract]   [Full Text] [Related]  

  • 28. Primary prevention cardiovascular disease: better than drugs.
    Pippin JJ
    Arch Intern Med; 2010 Nov; 170(20):1860-1; author reply 1861. PubMed ID: 21059984
    [No Abstract]   [Full Text] [Related]  

  • 29. [Simvastatin 40 mg as secondary prophylaxis: Effective, tolerable and cost-efficient!].
    Hernborg A; Hjemdahl P; Håkansson J
    Lakartidningen; 2006 Mar 15-21; 103(11):858, 861; discussion 861-2. PubMed ID: 16613120
    [No Abstract]   [Full Text] [Related]  

  • 30. [Statins in practice of the vascular surgeon and cardiologist].
    Pokrovskiĭ AV; Suntsov DS
    Angiol Sosud Khir; 2009; 15(2):123-7. PubMed ID: 19806952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternate-day statin therapy for the treatment of hyperlipidemia.
    Reindl EK; Wright BM; Wargo KA
    Ann Pharmacother; 2010 Sep; 44(9):1459-70. PubMed ID: 20702760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice].
    Olsson AG; Nilsson PM
    Lakartidningen; 2009 Mar 18-24; 106(12):854-7. PubMed ID: 19452786
    [No Abstract]   [Full Text] [Related]  

  • 33. Cost-effectiveness of statin medications.
    Kaplan RM; Golomb BA
    Am Psychol; 2001 Apr; 56(4):366-7. PubMed ID: 11330239
    [No Abstract]   [Full Text] [Related]  

  • 34. [The 4S study is analysed. Cholesterol reduction is cost-efficient].
    Jönsson B; Johannesson M; Olsson AG
    Lakartidningen; 1997 Dec; 94(51-52):4931-4. PubMed ID: 9454018
    [No Abstract]   [Full Text] [Related]  

  • 35. [Statins and cardiovascular disease prevention: use and prospective].
    Moulin P
    Nephrologie; 2000; 21(7):379-80. PubMed ID: 11200617
    [No Abstract]   [Full Text] [Related]  

  • 36. [Influence of pharmacologic cholesterol-lowering on the utilization of resources in health care--Significance of the Scandinavian Simvastatin Survival Study for cost reduction under Swiss conditions].
    Steurer J
    Schweiz Med Wochenschr; 1998 Jul; 128(29-30):1150-1. PubMed ID: 9715503
    [No Abstract]   [Full Text] [Related]  

  • 37. Pravastatin and coronary heart disease.
    Bloom JM
    N Engl J Med; 1999 Apr; 340(14):1116-7. PubMed ID: 10206831
    [No Abstract]   [Full Text] [Related]  

  • 38. [Contribution to statins?].
    Heebøll-Nielsen NC; Ahnfeldt-Mollerup I
    Ugeskr Laeger; 1998 Sep; 160(37):5376-7. PubMed ID: 9748871
    [No Abstract]   [Full Text] [Related]  

  • 39. Statins as cardioprotective agents.
    Piskur JR; Stone NJ
    Am J Manag Care; 2002 Jun; 8(9 Suppl):25-9. PubMed ID: 12099325
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical experience with ezetimibe/simvastatin in a Mediterranean population.
    Migdalis I; Efthimiadis A; Pappas S; Alexopoulos D; Vlasserou F; Mikhailidis DP
    Curr Med Res Opin; 2009 Oct; 25(10):2571-6. PubMed ID: 19739939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.